Seller's Market Shift

Business

Northland Cuts Bitdeer Price Target to $25 After December Update, Maintains Bullish Stance

Northland Capital has revised its price target for Bitdeer Technologies (BTDR) downward to $25, citing a more conservative valuation approach following the company's latest operational update. The firm, however, reaffirmed its Outperform rating, signaling continued confidence in the blockchain and high-performance computing firm's long-term strategy.

Jan 30, 2026

Business

Geron Sees Price Target Cut to $3 by TD Cowen Ahead of Q4, But Buy Rating Stays

Analyst Tara Bancroft of TD Cowen lowered the firm's price target on Geron Corporation (GERN) from $4 to $3, maintaining a Buy rating ahead of the biotech's fourth-quarter results. The move reflects a model update as the company navigates mixed commercial progress for its blood cancer drug RYTELO.

Jan 30, 2026

Business

Maxim Group Reiterates Bullish Stance on Strive (ASST), Sees 50% Upside to $1.50 Target

Investment firm Maxim Group reaffirms its Buy rating and $1.50 price target for Strive Inc., following the company's transformative acquisition of Semler Scientific, which positions it as a major corporate Bitcoin holder and expands its healthcare tech footprint.

Jan 30, 2026

Business

Citi Boosts Lexicon Pharmaceuticals Outlook on Novo Nordisk Partnership Progress

Citi raises Lexicon Pharmaceuticals' price target to $2.10, citing strong momentum from its collaboration with Novo Nordisk on obesity drug candidate LX9851 and improved financials.

Jan 30, 2026

Business

Sweetgreen Shares Slump Amid Growth Stock Sell-Off, Goldman Sachs Maintains Sell Rating

The fast-casual salad chain's stock fell sharply this week, pressured by a broader retreat in growth stocks and a reiterated sell call from Goldman Sachs, despite positive signals from the broader restaurant sector.

Jan 30, 2026

Business

Reed Jobs Launches $200M+ Venture Fund Aiming to Turn Cancer into a Manageable Condition

Reed Jobs, son of the late Apple co-founder Steve Jobs, has secured over $200 million for Yosemite, a venture fund dedicated to pioneering cancer treatments. Backed by major institutions, the fund seeks to transform cancer from a fatal diagnosis to a chronic, manageable disease within a generation.

Jan 30, 2026

Business

Fiserv's Plunge: A Value Trap or a Turnaround Bet for 2026?

Once a fintech stalwart, Fiserv shares have cratered 70% in a year. As its 'One Fiserv' restructuring plan kicks in, investors are grappling with whether the beaten-down stock is a bargain or a warning sign.

Jan 30, 2026

Business

OpenAI's Reported 2026 IPO: A High-Stakes Test for the AI Investment Frenzy

Sources indicate OpenAI is accelerating plans for a late-2026 public listing, a move that would place its massive cash burn and long road to profitability under intense investor scrutiny, potentially defining the next phase of the AI boom.

Jan 30, 2026

Business

Bloomin' Brands Faces Headwinds: Debt, Stagnant Sales Cloud Outlook

Shares of restaurant operator Bloomin' Brands have tumbled over 35% in six months, raising questions about its financial health and growth trajectory as analysts flag significant risks.

Jan 30, 2026

Business

Darling Ingredients' Rally Raises Eyebrows: Analysts Flag Concerns, Suggest Alternative Play

Despite a 39% surge in six months, Darling Ingredients faces scrutiny over its long-term sales decline, margin pressures, and falling profitability. Analysts point investors toward more resilient sectors.

Jan 30, 2026

Business

Walker & Dunlop's Slide: Three Red Flags for Investors and a Safer Alternative

While the S&P 500 has climbed, Walker & Dunlop shares have tumbled over 14% in six months. We analyze the underlying weaknesses in its financials and highlight a more compelling opportunity for value-focused portfolios.

Jan 30, 2026

Business

Therapeutics Sector Shows Resilience in Q3: United Therapeutics Lags as Halozyme and Biogen Outperform

A mixed third-quarter earnings season for therapeutics stocks reveals divergent paths, with United Therapeutics missing estimates while peers like Halozyme and Biogen post strong beats. Sector-wide revenue growth and positive stock reactions suggest underlying investor confidence despite regulatory and pricing headwinds.

Jan 30, 2026

World

Immigrant Rights Groups Sue ICE Over Policy Allowing Warrantless Home Entries

A coalition of immigrant advocacy organizations has filed a federal lawsuit challenging a newly revealed ICE policy that permits agents to enter private residences without judicial warrants, arguing it violates constitutional protections against unreasonable searches.

Jan 30, 2026

World

UK PM Announces China Lifts Sanctions on Six British Parliamentarians Amid Thawing Ties

Prime Minister Keir Starmer confirmed during his Beijing visit that China has removed sanctions against six UK MPs and peers, a move signaling a diplomatic reset after years of tension over human rights concerns.

Jan 30, 2026

World

Poland Points Finger at Russian Spy Agency Over Destructive Year-End Cyberattacks on Critical Infrastructure

Polish cybersecurity authorities have attributed a wave of disruptive cyberattacks in late December to a hacking group linked to Russia's FSB, marking a potential escalation in tactics against energy and heating infrastructure during a severe winter storm.

Jan 30, 2026

Business

Haemonetics Gains Analyst Backing After Strategic Vivasure Buyout

Haemonetics (NYSE:HAE) sees its price target raised by Barrington Research following its acquisition of Vivasure Medical, with analysts highlighting the deal's potential to bolster its medical device portfolio and drive growth.

Jan 30, 2026

Business

OneSeven Bolsters Leadership Amid Rapid Growth, Nears $9 Billion in Assets

The Cleveland-based RIA platform has appointed three senior executives as its assets under management soar, positioning the firm for its ambitious target of $20 billion by 2027.

Jan 30, 2026

Business

Advocate Health Announces Major Compensation Overhaul, Boosting Minimum Wage and Benefits Across Six States

Advocate Health, the nation's third-largest nonprofit health system, is investing over $800 million in enhanced compensation and benefits for its 165,000+ employees, raising its minimum wage and expanding tuition aid, mental health support, and paid volunteer time.

Jan 30, 2026

Business

Three Mid-Cap Stocks Under the Microscope: Growth Potential Meets Mounting Risks

Mid-cap companies offer a compelling blend of established operations and growth runway, but they navigate a perilous landscape between industry titans and agile disruptors. We examine three stocks where investor optimism may be overlooking critical challenges.

Jan 30, 2026

Business

Q3 Earnings Spotlight: How WillScot Mobile Mini Stacks Up Against Construction Services Peers

As earnings season concludes, we analyze the performance of construction and maintenance services stocks. While the sector showed overall strength, WillScot Mobile Mini faced headwinds, contrasting with standout results from peers like Comfort Systems.

Jan 30, 2026